Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

University of North Carolina, Chapel Hill: Clinical Trials & FDA Approval Profile

University of North Carolina, Chapel Hill (Global / Institutional) sponsors 49 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 10 active protocols (6 recruiting now), 26 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)26.5%
Median Closed Enrollment vs National (145 pts)24 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for University of North Carolina, Chapel Hill
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)49
Active Pipeline (Recruiting Now)10 (6)
Completed vs Stopped Early26 / 13 (26.5%)
Median Closed Actual Enrollment24 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With University of North Carolina, Chapel Hill
Hospital Research SiteLocationShared Protocols
University of North Carolina at Chapel HillChapel Hill, NC7
University of North CarolinaChapel Hill, NC6
Washington University and Siteman Cancer CenterSaint Louis, MO4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by University of North Carolina, Chapel Hill
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06636786Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)Phase IIRECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for UNC Health across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the University of North Carolina, Chapel Hill Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI